PhaseBio To Report First Quarter 2019 Financial Results and Recent Corporate Progress on May 9, 2019

Financial Results

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, announced it will report financial and business results for the first quarter 2019 and recent corporate progress on May 9, 2019, after the close of the U.S. financial markets.

For more information on PhaseBio and to receive PhaseBio’s press releases, please visit the Investors section of the company’s website at and register for email alerts.

Source: PhaseBio Pharmaceuticals, Inc., One Great Valley Parkway, Suite 30, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee